SKYE BIOSCIENCE
Skye Bioscience is a biopharmaceutical company focused on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds called cannabinoids, designed to alleviate a variety of diseases and symptoms by selectively targeting CB1 and CB2 receptors. Skye Bioscience is developing a novel and proprietary class of product candidates that are designed to target the body's nervous and immune systems without inducing many of the undesirable side effects typically associated with currently available therapeutics.
SKYE BIOSCIENCE
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2011-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.skyebioscience.com
Total Employee:
1+
Status:
Active
Contact:
(949) 396-0330
Total Funding:
43.84 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Microsoft Exchange Online Amazon Office 365 Mail GoDaddy DNS Google Google Cloud COVID-19
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Aptose Biosciences
Aptose Biosciences is a biopharmaceutical company focused on the discovery, research and development of novel, first-in-class
Oyster Point Pharmaceuticals
Oyster is a clinical stage pharmaceutical company focused on the discovery development & commercialization .
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Samorn Biosciences
Samorn Biosciences is a pharmaceuticals industry that focuses on the development, medical affairs and commercial services.
Stealth BioTherapeutics
Stealth BioTherapeutics is a clinical-stage biotechnology company focused on genetic diseases.
Current Employees Featured
Dennis D. Kim Chief Medical Officer @ Skye Bioscience
Chief Medical Officer
Punit Dhillon Chief Executive Officer @ Skye Bioscience
Chief Executive Officer
Kaitlyn Arsenault Chief Financial Officer @ Skye Bioscience
Chief Financial Officer
2021-10-01
Cosmas Lykos Executive Chairman and Co-Founder @ Skye Bioscience
Executive Chairman and Co-Founder
Tu Diep Chief Development Officer @ Skye Bioscience
Chief Development Officer
Founder
Stock Details
Investors List
SCHNEIDER Brothers
SCHNEIDER Brothers investment in Post-IPO Equity - Skye Bioscience
Midtown Partners
Midtown Partners investment in Post-IPO Equity - Skye Bioscience
TYLT Ventures
TYLT Ventures investment in Post-IPO Equity - Skye Bioscience
TYLT Ventures
TYLT Ventures investment in Post-IPO Equity - Skye Bioscience
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-03 | Skye Bioscience Retains Novotech as CRO for Phase 1 Trial of Glaucoma Drug Candidate |
| 2021-10-05 | Skye Bioscience Appoints Kaitlyn Arsenault as Chief Financial Officer |
Official Site Inspections
http://www.skyebioscience.com
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Skye Bioscience"
Skye Bioscience — Innovative Approach to Drug Development
We are a biopharmaceutical company focused on the development of proprietary cannabinoid derivatives for the treatment of glaucoma and other diseases with significant unmet medical …See details»
Skye Bioscience Appoints Dr. Karen Smith to Board of Directors
Jul 3, 2024 ir@skyebioscience.com (858) 410-0266. LifeSci Advisors, Mike Moyer mmoyer@lifesciadvisors.com (617) 308-4306. Media Inquiries LifeSci Communications, …See details»
Company Information - Skye Bioscience, Inc.
Company Contact Skye Bioscience, Inc. 11250 El Camino Real Suite 100 San Diego, CA 92130See details»
Investor Relations :: Skye Bioscience, Inc. (SKYE)
Company. Skye Bioscience, Inc. 11250 El Camino Real Suite 100 San Diego, CA 92130See details»
Skye Bioscience, Inc. (SKYE) Company Profile & Facts - Yahoo …
See the company profile for Skye Bioscience, Inc. (SKYE) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Skye Bioscience - Crunchbase Company Profile
Organization. Skye Bioscience . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Skye Bioscience is a pharmaceutical company developing new therapeutic …See details»
Skye Bioscience Inc. | LinkedIn
Skye Bioscience (Nasdaq: SKYE) is focused on unlocking new therapeutic pathways for metabolic health through the development of next-generation molecules that modulate G-protein coupled receptors ...See details»
Skye Bioscience Inc (SKYE-Q) Profile - The Globe and Mail
Mar 25, 2001 See the company profile for Skye Bioscience Inc (SKYE-Q) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Contact - Skye Bioscience
Skye Bioscience Inc. 11250 El Camino Real Suite 100 San Diego, CA 92130See details»
Skye Bioscience, Inc. (SKYE) Company Profile & Overview - Stock …
11250 El Camino Real, Suite 100 San Diego, California 92130 United StatesSee details»
Skye Bioscience, Inc. (SKYE) Stock Price, News, Quote & History
Find the latest Skye Bioscience, Inc. (SKYE) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Skye Bioscience Provides 2025 Look Ahead and Year in Review
5 days ago This study is also assessing the combination of nimacimab and a GLP-1R agonist (Wegovy®). For more information, please visit: www.skyebioscience.com. Connect with us on …See details»
Skye Bioscience receives positive safety review of topical …
Feb 25, 2023 Skye Bioscience Inc. has also retained Lexitas Pharma Services Inc. as the contract research organization (CRO) for its Phase 2a study of SBI-100 OE. 2. Tu Diep, Chief …See details»
Terms of Use — Skye Bioscience
If you are an individual accessing or using this website on behalf of, or for the benefit of, any corporation, partnership or other entity with which you are associated (an “organization”), then …See details»
Skye Bioscience, Inc. (Skye Bioscience, Inc.) - 药物管线_专利_临床 …
CONTACTS Investor Relationsir@skyebioscience.com(858) 410-0266 LifeSci Advisors, Mike Moyermmoyer@lifesciadvisors.com(617) 308-4306 Media InquiriesLifeSci Communications, …See details»
Skye Bioscience Reports Third Quarter 2024 Financial Results and …
Nov 7, 2024 ir@skyebioscience.com (858) 410-0266. LifeSci Advisors, Mike Moyer mmoyer@lifesciadvisors.com (617) 308-4306. Media Inquiries LifeSci Communications, …See details»
Skye Bioscience provides 2025 look ahead, anticipated milestones
6 days ago Skye Bioscience enters 2025 positioned to announce Phase 2 data for nimacimab, a non-incretin mechanism and first-in-class, peripherally-restricted CB1 inhibitor antibody with …See details»
Obesity — Skye Bioscience
CB1 inhibition is a differentiated energy-modulating and fat-burning mechanism with evidence showing its capability to induce weight loss. Skye is advancing its next-generation peripheral …See details»
Skye Bioscience Hosts Virtual KOL Event, “Metabolic Rewiring with …
Jul 24, 2024 Skye introduces collaboration with Beacon Biosignals to evaluate potential impact of Nimacimab on sleep quality and sleep apnea. SAN DIEGO, July 24, 2024 (GLOBE …See details»
Skye Bioscience Provides 2025 Look Ahead and Year in Review
6 days ago ir@skyebioscience.com (858) 410-0266. LifeSci Advisors, Mike Moyer mmoyer@lifesciadvisors.com (617) 308-4306. Media Inquiries LifeSci Communications, …See details»